Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-19

Clinical Trial Update: Canadian Pradaxa Acute Stroke Safety Study

View source ↗

Summary

A completed Canadian safety study of Pradaxa (dabigatran) in acute stroke/Transient Ischemic Attack patients with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pradaxa (dabigatran etexilate)

Snippet

Sponsor: University of Alberta | Conditions: Ischemic Attack, Transient, Stroke | Status: COMPLETED | Results posted: 2020-06-19